Synaptic inhibition of smooth muscles of the human colon: Effects of vitamin B6 and its derivatives

[1]  M. Shuba,et al.  Mechanisms of non-adrenergic non-cholinergic synaptic transmission in smooth muscle cells of the gastrointestinal tract , 1998, Neurophysiology.

[2]  O. V. Romanenko,et al.  [Blocking action of pyridoxal-5'-phosphate on nonadrenergic synaptic inhibition of human small intestine smooth muscle]. , 2006, Fiziolohichnyi zhurnal.

[3]  N. Hibi,et al.  Regulation of pyridoxal-5′-phosphate level by biogenic amines in mouse brain , 2006, Neurochemical Research.

[4]  M. Shuba,et al.  Ultrasound-induced changes in synaptic processes with different transmitters in smooth muscles , 2005, Neurophysiology.

[5]  M. Shuba,et al.  Synaptic processes in smooth muscles , 2005, Neurophysiology.

[6]  M. Shuba,et al.  Nonadrenergic inhibition of human intestinal smooth muscle , 2005, Neurophysiology.

[7]  M. Shuba,et al.  Mechanisms of the Inhibitory Action of Neurotransmitters on Smooth Muscles , 2003, Neurophysiology.

[8]  A. V. Romanenko,et al.  Effects of Pyridoxal 5′-Phosphate on Synaptic Transmission in Smooth Muscle , 2000, Neurophysiology.

[9]  P. Baxter.  Pyridoxine-dependent seizures: a clinical and biochemical conundrum. , 2003, Biochimica et biophysica acta.

[10]  P. Ueland,et al.  Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study. , 2003, Clinical chemistry.

[11]  M. Kassack,et al.  Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists. , 2002, Current pharmaceutical design.

[12]  R. Katholi,et al.  Clinical adaptation of a high-performance liquid chromatographic method for the assay of pyridoxal 5'-phosphate in human plasma. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[13]  Takao Takahashi,et al.  CSF glutamate/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control , 2001, Brain and Development.

[14]  C. Kennedy,et al.  Characterization of the ATPase released during sympathetic nerve stimulation of the guinea‐pig isolated vas deferens , 2000, British journal of pharmacology.

[15]  P. Andrews,et al.  Fundamentals of neurogastroenterology , 1999, Gut.

[16]  G. Farrugia,et al.  ATP is a mediator of the fast inhibitory junction potential in human jejunal circular smooth muscle. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[17]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[18]  V. Zagorodnyuk,et al.  Pharmacological evidence for the existence of multiple P2 receptors in the circular muscle of guinea‐pig colon , 1998, British journal of pharmacology.

[19]  V. Zagorodnyuk,et al.  The possible role of ATP and PACAP as mediators of apamin‐sensitive NANC inhibitory junction potentials in circular muscle of guinea‐pig colon , 1996, British journal of pharmacology.

[20]  B. Khakh,et al.  P2 purinoceptor antagonist properties of pyridoxal-5-phosphate. , 1994, European journal of pharmacology.

[21]  J. Szurszewski,et al.  Nitric oxide mediates inhibitory nerve input in human and canine jejunum. , 1993, Gastroenterology.

[22]  A. Cuello,et al.  Afferents to the basal forebrain cholinergic cell area from pontomesencephalic—catecholamine, serotonin, and acetylcholine—neurons , 1989, Neuroscience.

[23]  Artemenko Dp,et al.  Modification of the single sucrose gap method , 1982 .

[24]  Khmelevskiĭ Nm,et al.  Diabetic gastroparesis mimicking acute intestinal obstruction , 1981 .

[25]  Ira T. Lott,et al.  Vitamin B6‐dependent seizures , 1978, Neurology.